Goodys PM Pain Reliever

Manufacturer: Medtech Products Inc.
Effective date: 2024-10-25
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: full-release
Hydrated at: 2026-06-01 00:32:21

Label at a glance#

ProductGOODYS PM

Active ingredientACETAMINOPHEN, DIPHENHYDRAMINE CITRATE

Label structure10 sections

Indications and uses

• temporary relief of occasional headaches and minor aches and pains with accompanying sleeplessness

Dosage and administration

• do not take more than directed (see overdose warning ) • adults and children 12 years of age and over: take 2 powders at bedtime, if needed, or as directed by a doctor. Drink a full glass of water with each dose, or may stir powder into a glass of water or other liquid. • do not give to children under 12 years of age

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-866-255-5197

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

(in each powder)
Acetaminophen 500 mg
Diphenhydramine Citrate 38 mg

Purposes

OTC - PURPOSE SECTION

Pain reliever
Nighttime sleep-aid

Uses

INDICATIONS & USAGE SECTION

• temporary relief of occasional headaches and minor aches and pains with accompanying sleeplessness

Warnings

WARNINGS SECTION

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take

• more than 4,000 mg of acetaminophen in 24 hours
• with other drugs containing acetaminophen
• 3 or more alcoholic drinks every day while using this product

Allergy Alert: Acetaminophen may cause severe skin reactions. Symptoms may include:

● skin reddening ● blisters ● rash. If a skin reaction occurs, stop use and seek medical help right away.

Do not use

OTC - DO NOT USE SECTION

• with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
• in children under 12 years of age
• with any other product containing diphenhydramine, even one used on skin

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

• liver disease
• glaucoma
• a breathing problem such as emphysema or chronic bronchitis
• trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are taking

OTC - ASK DOCTOR/PHARMACIST SECTION

• the blood thinning drug warfarin
• sedatives or tranquilizers

When using this product

OTC - WHEN USING SECTION

• drowsiness will occur
• avoid alcoholic drinks
• be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

OTC - STOP USE SECTION

• sleeplessness persists continuously for more than 2 weeks. Insomnia may be a symptom of a serious underlying medical illness.
• pain gets worse or lasts more than 10 days
• redness or swelling is present
• any new symptoms appear
These could be signs of a serious condition.

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Overdose warning:

OVERDOSAGE SECTION

Taking more than the recommended dose can cause serious health problems. In case of overdose, get medical help or contact Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

Directions

DOSAGE & ADMINISTRATION SECTION

• do not take more than directed (see overdose warning)
• adults and children 12 years of age and over: take 2 powders at bedtime, if needed, or as directed by a doctor. Drink a full glass of water with each dose, or may stir powder into a glass of water or other liquid.
• do not give to children under 12 years of age

Other Information

OTHER SAFETY INFORMATION

• each powder contains: potassium 42 mg
• store below 25°C (77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

citric acid, docusate sodium, fumaric acid, glycine, lactose monohydrate, magnesium stearate, potassium chloride, silica gel, sodium benzoate, sodium citrate dihydrate

Questions or comments?

OTC - QUESTIONS SECTION

1-866-255-5197

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Goody’s PM
Acetaminophen • Diphenhydramine Citrate
Pain Reliever/ Nighttime sleep-aid
FOR PAIN WITH SLEEPLESSNESS
16 Powder Packs

Principal Display Panel Goody’s PM Acetaminophen • Diphenhydramine Citrate Pain Reliever/ Nighttime sleep-aid FOR PAIN WITH SLEEPLESSNESS 16 Powder Packs

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1297947	acetaminophen 500 MG / diphenhydrAMINE citrate 38 MG Oral Powder	PSN	5
1297947	acetaminophen 500 MG / diphenhydramine citrate 38 MG Oral Powder	SCD	5
1297947	APAP 500 MG / Diphenhydramine Citrate 38 MG Oral Powder	SY	5

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
DIPHENHYDRAMINE Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
0e2e0f88-b076-afe1-4bdd-32bca4375bec	Product name	3	20250127
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
3e48c9c4-918d-5d23-2f0b-d2398b06be54	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
865c72dd-0d94-daac-f728-ddd4ded2a79e	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63029-661-01	2020-04-23	C162847	48780-1	9d75b9d0-16b1-f424-e053-dadaa90a57ce	Goodys PM - 63029-656
63029-661-02	2020-04-23	C162847	48780-1	9d75b9d0-16b1-f424-e053-dadaa90a57ce	Goodys PM - 63029-656
63029-661-01	2020-01-31	C162847	48780-1	9d75b9d0-16b1-f424-e053-dadaa90a57ce	Goodys PM - 63029-656
63029-661-02	2020-01-31	C162847	48780-1	9d75b9d0-16b1-f424-e053-dadaa90a57ce	Goodys PM - 63029-656

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
63029-656-06	GOODYS PM	6 in 1 CARTON	POWDER	6		5
63029-656-16	GOODYS PM	16 in 1 CARTON	POWDER	16		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63029-656	GOODYS PM (ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE) POWDER [MEDTECH PRODUCTS INC.]	5	Current NDC, Legacy NDC, 2 package rows	20241101_db5d6c2b-688e-4e88-a42d-0fa2b0d8140b.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	2
DIPHENHYDRAMINE CITRATE	ACTIVE INGREDIENT	4OD433S209	2
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	2
DIPHENHYDRAMINE	ACTIVE MOIETY	8GTS82S83M	2
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	2
DOCUSATE SODIUM	INACTIVE INGREDIENT	F05Q2T2JA0	2
FUMARIC ACID	INACTIVE INGREDIENT	88XHZ13131	2
GLYCINE	INACTIVE INGREDIENT	TE7660XO1C	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	2
POTASSIUM CHLORIDE	INACTIVE INGREDIENT	660YQ98I10	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	2
TRISODIUM CITRATE DIHYDRATE	INACTIVE INGREDIENT	B22547B95K	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

GOODYS PM
Acetaminophen and Diphenhydramine Citrate
ACETAMINOPHEN
DIPHENHYDRAMINE CITRATE
DIPHENHYDRAMINE
CITRIC ACID MONOHYDRATE
DOCUSATE SODIUM
FUMARIC ACID
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
POTASSIUM CHLORIDE
SILICON DIOXIDE
SODIUM BENZOATE
TRISODIUM CITRATE DIHYDRATE
GLYCINE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
63029-656	63029-656-16, 63029-656-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
ACETAMINOPHEN	362O9ITL9D	ACTIB
DIPHENHYDRAMINE CITRATE	4OD433S209	ACTIB
CITRIC ACID MONOHYDRATE	2968PHW8QP	IACT
DOCUSATE SODIUM	F05Q2T2JA0	IACT
FUMARIC ACID	88XHZ13131	IACT
LACTOSE MONOHYDRATE	EWQ57Q8I5X	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
POTASSIUM CHLORIDE	660YQ98I10	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
TRISODIUM CITRATE DIHYDRATE	B22547B95K	IACT
GLYCINE	TE7660XO1C	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 204 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER / ORAL		50 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
DOCUSATE SODIUM	DOCUSATE SODIUM	F05Q2T2JA0	SUSPENSION, EXTENDED RELEASE / ORAL	0.77 mg		Exact identifier — unii+route 24 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SOLUTION / ORAL		660 mg	Exact identifier — unii+route 57 equally ranked IID candidates
DOCUSATE SODIUM	DOCUSATE SODIUM	F05Q2T2JA0	TABLET / ORAL		50 mg	Exact identifier — unii+route 24 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE, DELAYED RELEASE / ORAL		50 mg	Exact identifier — unii+route 27 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET, DELAYED RELEASE / ORAL	0.34 mg		Exact identifier — unii+route 57 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GRANULE, EFFERVESCENT / ORAL	60 mg		Exact identifier — unii+route 57 equally ranked IID candidates
LACTOSE MONOHYDRATE	LACTOSE MONOHYDRATE	EWQ57Q8I5X	POWDER / ORAL		50 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	POWDER / ORAL		840 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	CAPSULE, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii+route 18 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	SOLUTION / ORAL		1200 mg	Exact identifier — unii+route 45 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	TABLET, CHEWABLE / ORAL		14 mg	Exact identifier — unii+route 45 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	TABLET, CHEWABLE / ORAL		14 mg	Exact identifier — unii+route 45 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	POWDER / NASAL	NA		Exact identifier — unii+dosage form 18 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	POWDER / RESPIRATORY (INHALATION)		17 mg	Exact identifier — unii+dosage form 45 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION/ DROPS / ORAL		23 mg	Exact identifier — unii+route 57 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	SUSPENSION, EXTENDED RELEASE / ORAL		9 mg	Exact identifier — unii+route 45 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	CAPSULE / ORAL		35 mg	Exact identifier — unii+route 45 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	SUSPENSION / ORAL		5013 mg	Exact identifier — unii+route 45 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	TABLET / ORAL		896 mg	Exact identifier — unii+route 45 equally ranked IID candidates
DOCUSATE SODIUM	DOCUSATE SODIUM	F05Q2T2JA0	SUSPENSION / ORAL		48 mg	Exact identifier — unii+route 24 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	POWDER, FOR SUSPENSION / ORAL		5010 mg	Exact identifier — unii+route 45 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	SOLUTION / ORAL	50 mg		Exact identifier — unii+route 27 equally ranked IID candidates
DOCUSATE SODIUM	DOCUSATE SODIUM	F05Q2T2JA0	TABLET, FILM COATED / ORAL		6 mg	Exact identifier — unii+route 24 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SOLUTION / ORAL	0.09 mg		Exact identifier — unii+route 27 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SYRUP / ORAL		80 mg	Exact identifier — unii+route 57 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	CAPSULE / ORAL		62 mg	Exact identifier — unii+route 27 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION/ DROPS / ORAL		23 mg	Exact identifier — unii+route 57 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	TABLET / ORAL		231 mg	Exact identifier — unii+route 18 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	CAPSULE / ORAL	8.5 mg		Exact identifier — unii+route 57 equally ranked IID candidates
DOCUSATE SODIUM	DOCUSATE SODIUM	F05Q2T2JA0	TABLET, FILM COATED / ORAL		6 mg	Exact identifier — unii+route 24 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SOLUTION / ORAL	0.09 mg		Exact identifier — unii+route 27 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SOLUTION / ORAL		660 mg	Exact identifier — unii+route 57 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	CAPSULE, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii+route 18 equally ranked IID candidates
FUMARIC ACID	FUMARIC ACID	88XHZ13131	POWDER, FOR SOLUTION / ORAL	2 mg/1ml		Exact identifier — unii+route 21 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	POWDER, FOR SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 27 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	TABLET / ORAL		231 mg	Exact identifier — unii+route 18 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	ELIXIR / ORAL		120 mg	Exact identifier — unii+route 45 equally ranked IID candidates
FUMARIC ACID	FUMARIC ACID	88XHZ13131	TABLET / ORAL		115 mg	Exact identifier — unii+route 21 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET, FILM COATED / ORAL		1 mg	Exact identifier — unii+route 57 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	GRANULE, FOR SUSPENSION / ORAL		4950 mg	Exact identifier — unii+route 45 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	POWDER, FOR SOLUTION / ORAL		98 mg	Exact identifier — unii+route 57 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET / ORAL	163.31 mg		Exact identifier — unii+route 27 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET / ORAL	30 mg		Exact identifier — unii+route 57 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	POWDER / RESPIRATORY (INHALATION)	0.18 mg		Exact identifier — unii+dosage form 18 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	CAPSULE / ORAL		35 mg	Exact identifier — unii+route 45 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	POWDER, FOR SOLUTION / ORAL		98 mg	Exact identifier — unii+route 57 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	POWDER, FOR SUSPENSION / ORAL		160 mg	Exact identifier — unii+route 57 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GRANULE, FOR SUSPENSION / ORAL		120 mg	Exact identifier — unii+route 57 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	POWDER, FOR SOLUTION / ORAL		98 mg	Exact identifier — unii+route 57 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	SUSPENSION / ORAL		5013 mg	Exact identifier — unii+route 45 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 57 equally ranked IID candidates
DOCUSATE SODIUM	DOCUSATE SODIUM	F05Q2T2JA0	CAPSULE, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 24 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 57 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION, EXTENDED RELEASE / ORAL		24 mg	Exact identifier — unii+route 57 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	PASTE / ORAL		28 mg	Exact identifier — unii+route 57 equally ranked IID candidates
FUMARIC ACID	FUMARIC ACID	88XHZ13131	TABLET / ORAL		115 mg	Exact identifier — unii+route 21 equally ranked IID candidates
GLYCINE	GLYCINE	TE7660XO1C	TABLET, CHEWABLE / ORAL		267 mg	Exact identifier — unii+route 27 equally ranked IID candidates
TRISODIUM CITRATE DIHYDRATE	TRISODIUM CITRATE DIHYDRATE	B22547B95K	GRANULE, FOR SUSPENSION / ORAL		4950 mg	Exact identifier — unii+route 45 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GOODYS PM	ACETAMINOPHEN AND DIPHENHYDRAMINE CITRATE	Medtech Products Inc.	db5d6c2b-688e-4e88-a42d-0fa2b0d8140b	2024-10-25	Warnings	Exact identifier ndc (package): 63029-656-06 ndc (package): 63029-656-16 ndc (product): 63029-656 ndc11 (package): 63029065616 ndc11 (package): 63029065606 spl id: ada25630-e145-4866-b173-435441e2688a spl set id: db5d6c2b-688e-4e88-a42d-0fa2b0d8140b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.